# Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion

> **NCT06350981** · PHASE2,PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Foundation for Orthopaedic Research and Education** · enrollment: 76 (estimated)

## Conditions studied

- Back Pain
- Surgery-Complications
- Narcotic Use
- Physical Stress
- Post Operative Pain

## Interventions

- **DRUG:** Exparel
- **DRUG:** Bupivacain

## Key facts

- **NCT ID:** NCT06350981
- **Lead sponsor:** Foundation for Orthopaedic Research and Education
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-04-30
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06350981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06350981, "Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06350981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*